HealthFlex
×
  • About Us
    • Company Management
    • Meet Our Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Careers
  • Technologies
    • Oncoprex® Delivery System
    • Reqorsa® Gene Therapy
    • GPX-002
  • Programs
    • Oncology
    • Diabetes
  • Clinical Trials
    • Pipeline
    • ONC-001
    • ONC-002
    • Acclaim-1
    • Acclaim-3
    • DIA-001 and DIA-002
    • Expanded Access Policy
  • Investors
    • Company Profile
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder FAQ
    • Downloads
    • Events
  • News
    • Press Releases
    • Blog Posts
    • Media Coverage
    • Videos
  • Contact
David M. Schloss

David M. Schloss

Senior Vice President of Human Resources

David Schloss has more than 25 years’ experience as a human resources executive and employment attorney in life sciences with a focus on biotech, cell and gene therapy and health care technology in both the public and private sectors.  He served as VP, Human Resources with GlaxoSmithKline before moving on to lead HR for multiple small to mid-size companies including ImClone Systems, Eurand Pharmaceuticals, OraPharma, Caladrius Biosciences and Teladoc Health, helping to take each through dramatic growth and evolution, often resulting is successful merger and acquisition.

Mr. Schloss has also served as Principal with DMS HR Consulting, LLC, where he worked with life sciences companies to deliver HR and business strategies that lead to profitable growth and value creation.  David’s focus has been on helping organizations navigate the most challenging elements of human resources which define their culture and values.  Additionally, Mr. Schloss has served as Of Counsel with Porzio Bromberg & Newman, where, as a member of the firm’s employment law team, he worked with clients to deliver HR and business strategies to senior management, offering advice and counsel in compensation, benefits, talent acquisition and development, organizational design, employee relations and HR compliance.

Mr. Schloss holds a BA degree from Clark University and a JD degree from The University of Miami School of Law and is a member of the Pennsylvania Bar Association.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

  • About Us
  • Clinical Trials
  • Investors
  • Downloads
  • Press Releases
  • X
  • Facebook
  • LinkedIn

Latest News

  • Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer Apr 30
  • Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting Apr 28
  • Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting Apr 22
  • Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy Apr 21
Designed and Secured by Barsec
Copyright ©2026 all rights reserved.
Home - Privacy Policy - Terms of Use